(Q51439320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

0 references

0 references

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Masashi Narazaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Toru Hirano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Nobuyuki Ohguro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Satoshi Hohki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Keisuke Hagihara

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Yoshihito Shima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Kazuyuki Yoshizaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Atsushi Kumanogoh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Tadamitsu Kishimoto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Toshio Tanaka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

12 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

298-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

EULAR recommendations for the management of Behçet disease

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

Tocilizumab for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

Behçet's disease: evaluation of a new instrument to measure clinical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-011-0497-5

10.3109/S10165-011-0497-5

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21748365%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference